Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001762893-25-000009
Filing Date
2025-01-30
Accepted
2025-01-30 16:02:12
Documents
1
Period of Report
2025-01-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1738270924.html 4  
1 FORM 4 wk-form4_1738270924.xml 4 3084
  Complete submission text file 0001762893-25-000009.txt   4547
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Issuer) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O EIGER BIOPHARMACEUTICALS, INC. 2155 PARK BLVD. PALO ALTO CA 94306
Business Address
Ryali Sriram (Reporting) CIK: 0001762893 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40631 | Film No.: 25573574